BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 184 filers reported holding BLUEBIRD BIO INC in Q4 2022. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $106,115 | +15.8% | 34,906 | +25.3% | 0.00% | – |
| Q2 2023 | $91,614 | -1.3% | 27,847 | -4.7% | 0.00% | – |
| Q1 2023 | $92,859 | -77.6% | 29,231 | -51.3% | 0.00% | -100.0% |
| Q4 2022 | $415,388 | +196.7% | 60,083 | +170.5% | 0.00% | – |
| Q3 2022 | $140,000 | +57.3% | 22,208 | +3.8% | 0.00% | – |
| Q2 2022 | $89,000 | -95.2% | 21,387 | -1.3% | 0.00% | -100.0% |
| Q1 2022 | $1,871,000 | +939.4% | 21,676 | +20.0% | 0.00% | – |
| Q4 2021 | $180,000 | -35.0% | 18,058 | +24.4% | 0.00% | -100.0% |
| Q3 2021 | $277,000 | -29.2% | 14,515 | +18.4% | 0.00% | 0.0% |
| Q2 2021 | $391,000 | +9.8% | 12,256 | +4.1% | 0.00% | 0.0% |
| Q1 2021 | $356,000 | -25.1% | 11,778 | +7.3% | 0.00% | 0.0% |
| Q4 2020 | $475,000 | -14.9% | 10,979 | +4.5% | 0.00% | -50.0% |
| Q3 2020 | $558,000 | +6.3% | 10,503 | +23.3% | 0.00% | 0.0% |
| Q2 2020 | $525,000 | +37.1% | 8,520 | +2.7% | 0.00% | 0.0% |
| Q1 2020 | $383,000 | – | 8,298 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Monashee Investment Management LLC | 125,000 | $13,131,000 | 5.55% |
| Cormorant Asset Management, LP | 275,000 | $28,889,000 | 4.79% |
| Eventide Asset Management | 569,700 | $59,847,000 | 3.73% |
| Crosspoint Capital Strategies, LLC | 28,937 | $3,040,000 | 2.66% |
| Casdin Capital, LLC | 65,000 | $6,828,000 | 2.53% |
| ARK Investment Management | 119,683 | $12,573,000 | 2.45% |
| RTW INVESTMENTS, LP | 104,383 | $10,965,000 | 2.31% |
| Taylor Wealth Management Partners | 38,368 | $4,031,000 | 1.82% |
| First Light Asset Management, LLC | 33,780 | $3,549,000 | 1.19% |
| Atika Capital Management LLC | 25,000 | $2,627,000 | 0.92% |